Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation
- PMID: 24884433
- PMCID: PMC4046143
- DOI: 10.1186/1471-2458-14-442
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation
Abstract
Background: Fewer Canadian seniors are vaccinated against pneumococcal disease than receive the influenza vaccine annually. Improved understanding of factors influencing pneumococcal vaccination among older adults is needed to improve vaccine uptake.
Methods: A self-administered survey measuring knowledge, attitudes, beliefs and behaviours about pneumococcal vaccination was administered to a cohort of seniors participating in a clinical trial of seasonal influenza vaccines at eight centers across Canada. Eligible participants were ambulatory adults 65 years of age or older, in good health or with stable health conditions, previously given influenza vaccine. The primary outcome was self-reported receipt of pneumococcal vaccination. Multi-variable logistic regression was used to determine factors significantly associated with pneumococcal vaccine receipt.
Results: A total of 863 participants completed questionnaires (response rate 92%); 58% indicated they had received the pneumococcal vaccine. Being offered the vaccine by a health care provider had the strongest relationship with vaccine receipt (AOR 23.4 (95% CI 13.4-40.7)). Other variables that remained significantly associated with vaccine receipt in the multivariable model included having heard of the vaccine (AOR 10.1(95% CI 4.7-21.7)), and strongly agreeing that it is important for adults > 65 to be vaccinated against pneumococcus (AOR 3.3 (95% CI 1.2-9.2)). Participants who were < 70 years of age were less likely to be vaccinated.
Conclusions: These results indicate healthcare recommendation significantly influenced vaccine uptake in this population of older adults. Measures to encourage healthcare providers to offer the vaccine may help increase coverage.
Similar articles
-
Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.Dig Liver Dis. 2018 Jun;50(6):563-567. doi: 10.1016/j.dld.2017.12.027. Epub 2018 Jan 2. Dig Liver Dis. 2018. PMID: 29371056
-
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.Vaccine. 2015 Jul 17;33(31):3703-8. doi: 10.1016/j.vaccine.2015.06.012. Epub 2015 Jun 11. Vaccine. 2015. PMID: 26073016
-
Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP).BMC Public Health. 2016 Feb 4;16:121. doi: 10.1186/s12889-016-2784-8. BMC Public Health. 2016. PMID: 26846202 Free PMC article.
-
Adult vaccination in three Eastern Mediterranean countries: current status, challenges and the way forward.Expert Rev Vaccines. 2024 Jan-Dec;23(1):1068-1084. doi: 10.1080/14760584.2024.2428806. Epub 2024 Dec 3. Expert Rev Vaccines. 2024. PMID: 39539060 Review.
-
Promoting influenza vaccination: insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC).Vaccine. 2015 Jun 4;33(24):2741-56. doi: 10.1016/j.vaccine.2015.04.064. Epub 2015 Apr 28. Vaccine. 2015. PMID: 25936726 Free PMC article. Review.
Cited by
-
Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study.Hum Vaccin Immunother. 2016 Jul 2;12(7):1891-9. doi: 10.1080/21645515.2016.1149661. Epub 2016 Apr 11. Hum Vaccin Immunother. 2016. PMID: 27064311 Free PMC article.
-
Changes in the Pneumococcal Vaccination Uptake and Its Determinants before, during, and after the COVID-19 Pandemic among Community-Living Older Adults in Hong Kong, China: Repeated Random Telephone Surveys.Vaccines (Basel). 2024 Aug 7;12(8):894. doi: 10.3390/vaccines12080894. Vaccines (Basel). 2024. PMID: 39204020 Free PMC article.
-
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention.Hum Vaccin Immunother. 2016 Apr 2;12(4):1080-4. doi: 10.1080/21645515.2015.1114196. Epub 2016 Jan 21. Hum Vaccin Immunother. 2016. PMID: 26795065 Free PMC article.
-
Hospital staff members' preferences about who should be prioritized to receive the COVID-19 vaccine: People with or without Alzheimer's disease?J Aging Stud. 2021 Dec;59:100982. doi: 10.1016/j.jaging.2021.100982. Epub 2021 Oct 30. J Aging Stud. 2021. PMID: 34794709 Free PMC article.
-
Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups.Hum Vaccin Immunother. 2020 Sep 1;16(9):2136-2143. doi: 10.1080/21645515.2020.1763739. Epub 2020 Jul 2. Hum Vaccin Immunother. 2020. PMID: 32614656 Free PMC article.
References
-
- Public Health Agency of Canada. Vaccine Preventable Diseases: Invasive Pneumococcal Disease. 2011. http://www.phac-aspc.gc.ca/im/vpd-mev/index-eng.php.
-
- Group ER. Canadian Adult National Immunization Coverage (Adult NICS) Survey. 2006.
-
- Public Health Agency of Canada (PHAC) Canadian Immunization Guide - Public Health Agency of Canada. 2007.
-
- Pfizer Canada Inc. Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) Product Monograph. Kirkland; 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical